A new therapeutic strategy for spotted fever group rickettsioses: a proposal for evaluating combination therapy with tetracycline and fluoroquinolones
Frontiers in Cellular and Infection Microbiology · 24.03.2026 · 16
DOI: 10.3389/fcimb.2026.1798936 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 24.03.2026. Verfasst von Kazuhiro Itoh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, NHO Awara National Hospital, Awara, Japan. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, NHO Awara National Hospital, Awara, Japan.
- Department of Community Health Science, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Zitieren
APA
Itoh, K., Tsutani, H., Mitsuke, Y., Ikawa, M., & Iwasaki, H. (2026). A new therapeutic strategy for spotted fever group rickettsioses: a proposal for evaluating combination therapy with tetracycline and fluoroquinolones. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1798936
Vancouver
Itoh K, Tsutani H, Mitsuke Y, Ikawa M, Iwasaki H. A new therapeutic strategy for spotted fever group rickettsioses: a proposal for evaluating combination therapy with tetracycline and fluoroquinolones. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1798936
BibTeX
@article{Itoh2026,
author = {Itoh, Kazuhiro and Tsutani, Hiroshi and Mitsuke, Yasuhiko and Ikawa, Masamichi and Iwasaki, Hiromichi},
title = {A new therapeutic strategy for spotted fever group rickettsioses: a proposal for evaluating combination therapy with tetracycline and fluoroquinolones},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1798936}
}
EUVIMED